Filer Snapshot

Malin Life Sciences Holdings Ltd

CIK 0001685138. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity Type

Company

Total Filings

17

Latest Filing

15 Jan 2025

Industry

n/a

Follow future filing-backed changes

Save this filer to return when a new filing changes the portfolio, large-stake, insider, or company context.

Save and revisit

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it

Best next click

Start with the summary below, then verify the strongest source-backed page for this filer.

  • Open 13F if you want portfolio holdings.
  • Open 13D/G or insider pages only when this CIK has those rows.
Open reporting owner context
Source: SEC Schedule 13D/G

SCHEDULE 13G/A filed on 15 Jan 2025 for CIK 0001685138.

View Source Filing
Business address
2 Harbour Square, Crofton Road, Dun Laoghaire, Co, Dublin, Ireland, ----
Top holdings (Schedule 13G)
PSTX
State of incorporation
Ireland
Fiscal year end
31 December

Filer intelligence

What SEC filings say about Malin Life Sciences Holdings Ltd

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Save filer

Quick read

  • 1 recent 13D/G stake row found; top row is PSTX at 0% ownership.
  • Forms 3/4/5 show insider context for PSTX worth $0.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes 1 rows

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 1 rows

Officer, director, and 10% owner holdings or transactions.

Open

13D/G large-stake context

PSTX

08 Jan 2025 · Common Stock

0%
Issuer page 13D/G history

Forms 3/4/5 insider context

PSTX

08 Jan 2025 · 10% owner

$0
Issuer page Owner page

Latest update

What changed recently for Malin Life Sciences Holdings Ltd

New filing available

Latest Schedule 13D/G period: 08 Jan 2025. Open the source-backed page to inspect the fresh filing or facts context.

Update date

15 Jan 2025

Page type

Filer profile

Latest period

08 Jan 2025

Schedule 13D/G context is visible from filings filed on 15 Jan 2025.

Open filer profile Browse recent public updates

Benchmark Context

Benchmark context for this company

Malin Life Sciences Holdings Ltd has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest Schedule 13D/G period: 08 Jan 2025. That gives you a fresh baseline before you compare this company with peers.

  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Open company facts Browse metric rankings

Filer Overview

Malin Life Sciences Holdings Ltd has filed 17 SEC EDGAR filings since 20 Sep 2016. Common forms include SCHEDULE 13G/A, 4, SC 13G/A, SC 13G and more.

Malin Life Sciences Holdings Ltd SEC filings Malin Life Sciences Holdings Ltd 13D/G history Malin Life Sciences Holdings Ltd owner filings

Latest Filings

Recent SEC filings for Malin Life Sciences Holdings Ltd with direct links to document and filing folders.

SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
15 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

OWNERSHIP DOCUMENT

Filing date
10 Jan 2025
Reporting date
08 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

SC 13G/A

Filing date
07 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

OWNERSHIP DOCUMENT

Filing date
10 Aug 2022
Reporting date
08 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

SC 13G/A

Filing date
10 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

OWNERSHIP DOCUMENT

Filing date
07 Dec 2021
Reporting date
06 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

OWNERSHIP DOCUMENT

Filing date
02 Dec 2021
Reporting date
30 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

OWNERSHIP DOCUMENT

Filing date
29 Nov 2021
Reporting date
24 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

OWNERSHIP DOCUMENT

Filing date
23 Nov 2021
Reporting date
19 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

OWNERSHIP DOCUMENT

Filing date
18 Nov 2021
Reporting date
16 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SCHEDULE 13G

Filing date
15 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SC 13G

Filing date
03 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39376

4

Filing date
15 Jul 2020
Reporting date
14 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-39376

3

Filing date
09 Jul 2020
Reporting date
09 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-37880

4

Filing date
02 Jul 2019
Reporting date
28 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-37880

FORM 4 SUBMISSION

Filing date
28 Sep 2016
Reporting date
26 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-37880

FORM 3 SUBMISSION

Filing date
20 Sep 2016
Reporting date
20 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing

About this filer

Malin Life Sciences Holdings Ltd files with the SEC under CIK 0001685138. This page aggregates EDGAR filings and related ownership activity.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .